Neuronal action potentials may regulate myelination, both during development 1-3 and during white matter plasticity in adulthood 4,5 . Possible mediators of neuronal activity include exocytosis 6-8 of glutamate 9,10 or GABA 11 , at synapses between unmyelinated axons and oligodendrocyte precursor cells 12 , or release of growth factors 10,13 . Within developing oligodendrocytes, these agents may alter the concentration of calcium 14 .
However, [Ca 2+ ] i transients were more than twofold longer in the somata (Fig. 1h ). The amplitude of transients (assessed as Δ F/F, where F is fluorescence of the genetically encoded calcium indicator GCaMP6s) declined in processes over the course of development and was smaller in somata than in processes throughout development ( Fig. 1i ).
To determine whether neuronal activity generated oligodendrocyte [Ca 2+ ] i transients, we stimulated action potentials electrically or blocked them by injecting tetrodotoxin (TTX) (or extracellular solution as a sham injection) into the hindbrain, from where it entered the spinal cord ( Fig. 2a-c ). Stimulated action potentials were detected as extracellular field potentials, which were stable during sham injections but abolished by TTX ( Fig. 2c ). Averaging responses to 10-s durations 50-Hz stimulation trains revealed that stimulation significantly increased [Ca 2+ ] i , both in processes that had not yet made a sheath ('nonsheath' , part of pre-OLs or early OLs; Fig. 2d ) and in sheaths of processes that were already myelinating ('sheath' , part of early OLs or OLs; Fig. 2e ). The [Ca 2+ ] i transient amplitude was larger in nonsheath than in sheath processes ( Fig. 2d,e ). Stimulation increased the frequency of [Ca 2+ ] i elevations ( Fig. 2f ,g) but by less than the 0.6 per min (one per 100 s) increase expected if every stimulation train evoked a [Ca 2+ ] i rise. Neuronal stimulation also evoked [Ca 2+ ] i rises in somata of cells with processes that had not yet made a sheath, but not in somata of cells that already had a sheath-forming process ( Fig. 2h-k) , implying that at this later developmental stage, neuronal activity releases factors that raise [Ca 2+ ] i in developing sheaths but not in somata.
Injecting extracellular solution had no effect on ongoing [Ca 2+ ] i transients in the processes and somata of oligodendrocyte-lineage cells, but TTX injection roughly halved the transient rate in processes ( Fig. 2l,m) . TTX produced a similar reduction of transient rate in somata of cells with nonsheath processes (Fig. 2n,o) . Thus, approximately half of the [Ca 2+ ] i transients in developing oligodendrocytes are driven by axonal action potentials, but the remainder occur independently of action potentials.
To determine whether myelin sheath [Ca 2+ ] i transients regulate sheath growth, we imaged growing sheaths in OLs for 10.5 min every hour for 5 h (Fig. 3a,b ). This allowed measurement of the [Ca 2+ ] i transient frequency without excessive fluorophore bleaching or phototoxicity while imaging structural changes over an extended period. Over 5 h, the lengths of myelin sheaths increased (44% of 68 sheaths studied), decreased (26%), showed no change (24%) or increased and then decreased (6%; Fig. 3c-e ). Plotting the total change of sheath length against the mean [Ca 2+ ] i transient rate in that sheath over 5 h revealed that sheath elongation correlated strongly with [Ca 2+ ] i transient rate ( Fig. 3f ; regression slope is different from zero, P = 10 −11 ). However, for a [Ca 2+ ] i transient rate lower than ~1 per 30 min, sheath retraction occurred. Thus, a threshold rate of [Ca 2+ ] transients may be needed to maintain sheath length at this developmental stage.
Similar plots showed that sheath elongation also correlated weakly but significantly ( Supplementary Fig. 2a Fig. 2d ). Thus, sheath development is correlated with local [Ca 2+ ] i changes but not with somatic changes that might alter gene expression. To assess the temporal relationship between [Ca 2+ ] i elevations and sheath length, we selected sheaths that showed no growth for at least 1 h ( Fig. 3c ) and aligned their time courses of sheath elongation and of [Ca 2+ ] i transient rate at the onset of growth ( Supplementary  Fig. 2e ). Plotting sheath growth per hour against mean [Ca 2+ ] i transient rate (assessed as the average of the rates in imaging periods bracketing that hour) suggested that an increase in transient rate triggers sheath elongation after ~1 h ( Fig. 3g ).
To demonstrate that the [Ca 2+ ] i transients, including those evoked by neuronal activity (Fig. 2) , mechanistically drive sheath elongation (rather than merely being correlated with elongation), we first modulated neuronal activity and hence the [Ca 2+ ] i transient rate, either . P values are from two-tailed tests: one-way ANOVA followed by Holm-Bonferroni-corrected t tests in g for 'all processes' and in h and i for 'processes'; Kruskal-Wallis followed by Dunn's test in g for per-process and for somata and in h,i for somata; two-way ANOVA followed by Holm-Sidak test in h,i for somata vs. processes. Data are mean ± s.e.m. In some experiments TTX or sham injections were made into the hindbrain; 15 min was allowed for diffusion to the imaged area. b, Stimulation: 50-Hz pulses for 10 s, repeated seven times every 100 s. c, Field potential recording (at 1 Hz) before and after TTX (9 animals) or sham solution (8 animals) injection showed abolition by TTX but not sham. Calcium imaging was performed before and after the injection (red vertical lines). d,e, [Ca 2+ ] i traces (mean ± s.e.m. in gray) averaged over seven periods without or with stimulation (red rectangles) in (d) 18 nonsheath-forming or (e) 45 sheath-forming processes. f,g, Mean ± s.e.m. (points are individual processes) rates of [Ca 2+ ] i transients without and with stimulation in (f) nonsheath-forming or (g) sheath-forming processes. h-k, As in d-g but for somata (n = 9 each for j and k). Experiments in d-k are from 5 animals. l,m, Rate of [Ca 2+ ] i transients before and after sham or TTX injections in (l) nonsheath-forming (n = 27 and 32 processes for sham and TTX respectively) or (m) sheath-forming processes (n = 59 and 61 processes for sham and TTX). n,o, As in l-m but for somata (n = 18 and 19 somata for sham and TTX in n; n = 25 and 27 somata for sham and TTX in o). Numbers of animals in l-o were as in c. Statistical tests used (all two-tailed): Wilcoxon signed-rank test in f,g,j; paired t test in k; repeated-measures ANOVA followed by Holm-Sidak for l-o. Data are mean ± s.e.m.
by increasing neuronal activity with stimulation or by decreasing it with TTX ( Fig. 3h ). Stimulation increased sheath elongation by 60% ( Fig. 3i ), while TTX reduced elongation by 43% ( Fig. 3j ). Second, we manipulated the [Ca 2+ ] i changes occurring within growing myelin sheaths by briefly whole-cell patch-clamping developing oligodendrocytes to introduce into them solutions of low (1 mM EGTA) or high (30 mM BAPTA) [Ca 2+ ] buffering power (with the same free [Ca 2+ ] i : ~63 nM; see Methods). Sheaths dialyzed with the weak calcium buffer continued to elongate over 3 h, while those dialyzed with the strong calcium buffer on average shortened (significantly different: P = 2 × 10 −4 ; Fig. 3k ). Thus, myelin sheath elongation is driven by [Ca 2+ ] i transients, including those evoked by neuronal activity.
In addition to the temporally isolated [Ca 2+ ] i transients associated with sheath lengthening, we observed a longer type of [Ca 2+ ] i event ('bursts'; Fig. 3l ) exhibiting repeated rises and falls of [Ca 2+ ] i (duration: 87.5 ± 15.8 s (mean ± s.e.m.), n = 7; mean Δ F/F: 0.52 ± 0.09. These were rare but, strikingly, occurred only in sheaths that were shortening (or transitioning from growing to shortening). Consequently, isolated transients and bursts were inversely correlated in their association with sheath behavior (Fig. 3l ). On average, [Ca 2+ ] i bursts contributed only 7.8 ± 2.8% of the Ca 2+ entry (calculated as ∫ Δ ∕ .
F F dt [
] ) in all sheaths; however, this was 0% in lengthening sheaths and 75.6 ± 2.2% in shortening sheaths with bursts. Dialysis with the BAPTA-containing internal solution would be expected to reduce [Ca 2+ ] i during these events, so the fact that sheaths shortened in this condition ( Fig. 3k ) suggests that a BAPTAinduced reduction of magnitude of the brief [Ca 2+ ] i transients dominated the effect on sheath length or that the large Ca 2+ entry occurring during bursts overwhelmed the BAPTA buffer.
Our data show that, like astrocytes 16 , developing oligodendrocytes in vivo exhibit spatially restricted [Ca 2+ ] i elevations. At early developmental stages, these can occur simultaneously in many cell processes (possibly due to simultaneous neuronal input), but as myelination proceeds they become independent in different growing sheaths ( Fig. 1 and Supplementary Fig. 1 ). Approximately half of these transients are evoked by action potentials, as they are blocked by TTX and their rate is increased by electrical stimulation (Fig. 2 ). They may be generated by synaptic input from unmyelinated axons 12 , although this is downregulated as oligodendrocytes mature 17 . The remainder of the transients appear to be generated spontaneously, perhaps by TRPA1 channels 16 in oligodendrocyte sheaths 18 . Conceivably, since [Ca 2+ ] i transients promote sheath growth, these spontaneous and activity-driven transients may underlie the activity-independent and activity-dependent forms of myelination reported previously 10 .
Lengthening of the myelin sheath is driven by the rate of [Ca 2+ ] i transients occurring ( Fig. 3 ) and, below a certain rate, sheaths shorten, so a minimum [Ca 2+ ] i transient rate may be needed to maintain sheath length. However, long-duration [Ca 2+ ] i bursts imparting a high calcium load were also associated with shortening. These results suggest that modest [Ca 2+ ] i elevations trigger sheath elongation, while very low or excessively large rises lead to sheath shortening. The [Ca 2+ ] i transients presumably control proteins regulating cytoskeletal growth and myelin assembly. A likely effector producing sheath elongation is the PI3K-Akt-mTOR pathway, which is Ca 2+ -activated 19 and promotes myelin growth when activated in oligodendrocytes 20 . Although our observations are in developing oligodendrocytes, it will be intriguing to determine whether the same is true in established sheaths in adult animals, given that myelin plasticity is increasingly invoked as a mechanism for learning 4,5 , as well as during remyelination following stroke, spinal cord injury or multiple sclerosis.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-017-0031-y.
Animals. The following transgenic zebrafish lines were used: tg(sox10:mRFP) vu234 (ref. 21 , kindly provided by D. Lyons, Edinburgh) and two lines generated in-house, tg(mbp:mCherry-CAAX) u4011 and tg(sox10:GCaMP6s) u4016 . The redfluorescing tg(sox10:mRFP) and tg(mbp:mCherry) lines were used to visualize oligodendrocyte structure early and late in development, respectively, and the green-fluorescing tg(sox10:GCaMP6s) line was used to detect [Ca 2+ ] i changes. To visualize the morphology of single cells, CRISPR/Cas9 was used to achieve mosaic expression of the mRFP fluorophore (see below). All experiments were performed in the nonpigmented nacre background (mitfa w2/w2 ). Embryos were collected by natural spawning and raised at 28.5 °C in fish water. Animal procedures were carried out in accordance with the guidelines of the UK Animals (Scientific Procedures) Act 1986 and European Directive 2010/63/EU. Animals were randomly assigned to different treatments.
Plasmid construction. Constructs were generated with Gateway cloning technology using the clones p5E-mbp 22 , p5E-sox10 (generated by excising the sox10 promoter from 23 p-4.9sox10:egfp and ligating into p5E-MCS), pME-GCaMP6s (generated in a BP reaction from pGP-CMV-GCaMP6s; Addgene) and components of the Tol2kit 24 : p3E-polyA, pME-mCherry-CAAX, pDestTol2pA2 and pDestTol2CG2. Vectors were recombined using LR Clonase II Plus (Invitrogen). Gateway BP Clonase II was used to generate pME-GCaMP6s.
Generation of transgenic zebrafish lines. Fertilized eggs were injected with 1 nL of solution containing 25 ng/μ L of plasmid DNA and 100 ng/μ L of transposase mRNA. Injected embryos were grown to adulthood and F1 offspring were screened by phenotype (expression of fluorescent protein in the appropriate cells) to identify F0 founders.
CRISPR mosaics. We used CRISPR/Cas9 genome editing to perform somatic inactivation (in most cells) of the mRFP transgene in a stable transgenic fish line tg(sox10:mRFP) vu234Tg to allow visualization of single developing oligodendrocytes. Guide RNA design was performed 25 with CHOPCHOP (https://chopchop.rc.fas. harvard.edu/) using the mRFP sequence as input. One-cell to 16-cell stage embryos were injected with 150 pg Cas9 and 30 pg mRFP gRNA (with target sequence GGCGAGGGCCGCCCCTACG), and embryos were selected for imaging based on their mosaic expression of the fluorescent marker.
Live imaging. At 3 d post fertilization (dpf), larvae were mounted in 1% LMP agarose (Sigma, made up in fish water) in 0.5 mg/mL mivacurium chloride (a neuromuscular blocker used to prevent movement; LKT Labs) and imaged at 28-29 °C with a Zeiss LSM780 two-photon/confocal microscope. A confocal stack was taken in an area between segments 8 and 14 of the spinal cord to record the morphology of developing oligodendrocytes (sox10:mRFP or mbp:mCherry-CAAX, excited at 561 nm). In calcium imaging experiments, GCaMP6s was two-photon excited at 940 nm, with an intensity at the preparation of 11 mW and a pixel dwell time of 2.55 μ s, using a W Plan-Apochromat 20 × objective with NA = 1.0. Stacks of five planes, 2 μ m apart, were acquired every 3.5 s for 10.5 min (180 stacks). In Fig. 1 calcium imaging was performed once for each field of view, in Fig. 2 it was performed twice for each field of view (control and stimulation, or control and TTX or sham injection) and in Fig. 3a -g,l it was done six times (every hour for 5 h; see Fig. 3a ). The spatial resolution provided by two-photon imaging did not allow us to define whether sheath [Ca 2+ ] i transients occur within the lamellae of the developing sheath or in the cytoplasmic tongues extending along the sheath. Lengths of myelin sheaths were measured in a maximum intensity projection of the GCaMP6s images, i.e., averaged over the 10.5 min of calcium imaging. This procedure was shown (in control experiments) to give the same measured length as when measuring the tg(sox10:RFP) or tg(mbp:mCherry) images. It is not possible to tell from our images the extent to which the sheaths have started compacting at the stage imaged (compaction is a gradual process, starting in the outer wraps, that occurs only as the sheath develops 26 ). This does not affect our conclusions in any way, since the great majority of the sheaths we are studying are destined to become compacted 15, 26 (and only a small fraction of sheaths are removed 15 ). ] > 0.275 frames for processes and > 0.24 frames for somata). Results of these analyses, which were carried out in Matlab, were manually checked against the original GCaMP6s recordings to exclude false positives (resulting from increases in background activity or activity in other cell processes). In Fig. 1g , the transient rate is shown for somata (averaged over cells), per process (calculated by obtaining the mean rate per process for each cell and then calculating the mean ± s.e.m. by averaging over all cells) and for all processes (calculated by averaging over all cells the product of [mean rate per process for each cell].
Image analysis. Regions of interest (ROIs
[number of processes on the cell]).
Duration of transients or bursts ( Fig. 1h and Supplementary Fig. 2b) was taken as the time during which they were above the detection threshold. Amplitude ( Fig. 1i and Supplementary Fig. 2a ) was taken as the magnitude of Δ F/F at the peak of the response relative to the time-smoothed baseline. The transient area ( Supplementary Fig. 2c ) was taken as the sum of (i) the area of the transient above the threshold and (ii) its base, which was taken as the duration of the transient multiplied by the threshold value (i.e., the area of the transient below the threshold). Rarely observed [Ca 2+ ] i bursts, defined as periods of raised [Ca 2+ ] i , with frequently alternating subthreshold and suprathreshold values of Δ F/F, with suprathreshold events constituting at least 55% of the frames, and with an overall duration greater than 40 s, were excluded from the analysis of transients for Fig. 3f and were analyzed separately for Fig. 3l . The burst area was calculated as the sum of the areas of each suprathreshold component of the burst plus its base. Mean burst amplitude was calculated as the burst area divided by its duration. The average rate (Fig. 3f) , amplitude, duration and area ( Supplementary Fig. 2a-c) of calcium transients were calculated using the flanking calcium recordings to obtain an average for each hour and then taking the sum of those and dividing it by the total duration of the experiment.
Electrical stimulation and pharmacology.
A stimulation electrode (glass capillary filled with 1 M NaCl) was inserted in the rostral spinal cord. For recording field potentials, a similar electrode (tip resistance 15-35 MΩ inside the spinal cord) was placed in the caudal spinal cord. Stimuli (single pulses applied at 1 Hz, or 50-Hz stimulus trains of 10 s duration) were generated with a GRASS S88 stimulator triggered with Clampex software (Axon Instruments, Molecular Devices). For these experiments, the fish was surrounded by fish extracellular solution (134 mM NaCl, 10 mM HEPES, 10 mM glucose, 2.9 mM KCl, 2.1 CaCl 2 and 1.2 mM MgCl 2 ) rather than fish water, to allow better current flow from the stimulation electrode to the ground electrode. Field potentials (for TTX experiments measured in voltage-clamp mode as currents) were recorded using an Axon Instruments MultiClamp 700B amplifier. Data were digitized at 10 kHz using an Axon Instruments Digidata 1440 (Molecular Devices). Stimulation strength was set to 15-100 V (depending on the electrode resistance) to reliably evoke field potentials. When imaging calcium with and without stimulation (Fig. 2b,d-k) , the periods of stimulation and no stimulation (control) were alternated, and [Ca 2+ ] i transient rate was measured in a 40-s time window that included the 10-s stimulation and the 30-s post-stimulation periods (equivalent time windows were analyzed in the control experiments, in which no stimulation was applied). To block action potentials in the spinal cord, 2 nL of fish extracellular solution containing 2 μM TTX was pressure injected into the brain using a Picospritzer III (Parker). Injections were calibrated to deliver 0.5 nL per pressure pulse (4 pulses were used for 2 nL). For control injections (sham), the same volume of extracellular solution without TTX was injected (no blinding of experimenters to the identity of the injected solution was used for these experiments). Movement of TTX from the injection site to the spinal cord (to inhibit action potentials) took < 1 min, and we waited 15 min to ensure that it reached the imaging site ( Fig. 2c ). Experiments in Fig. 3i were conducted with the stimulation and recording electrodes inserted but not the injection pipette; experiments in Fig. 3j were conducted with the injection pipette inserted but not the stimulation and recording electrodes.
Whole-cell patch-clamp loading of calcium buffer into oligodendrocytes in vivo.
After immobilization using 0.50-0.55 mg/mL mivacurium chloride dissolved in fish external solution, fish were pinned through the notochord to a Sylgardcoated recording chamber using fine tungsten needles. The skin was removed using a tungsten tool and fine tweezers, and the muscles aspirated using a suction electrode. Oligodendrocytes were identified by mCherry expression and patchclamped using 15-to 18-MΩ patch pipettes. Directly after establishing the wholecell configuration (with cells voltage-clamped at -55 mV), four or five brief 'zaps' (25-µ s, 1-V pulses applied from the Multiclamp 700B amplifier) were applied to load the cell with the internal solution (monitored by the spread of the Alexa Fluor 647 dye included in the internal solution). Directly after zapping, the patch pipette was retracted carefully to allow the membrane to reseal (monitored in voltageclamp mode). The tissue was allowed to relax for approximately 15 min before imaging. Image stacks (image size, 70.7 µ m × 41.4 μ m; pixel size, 0.14 μ m; z-step size, 1 µ m) of the patch-clamp loaded oligodendrocytes were taken every hour for a period of 3 h.
The control (low calcium buffering power) internal solution contained (in mM) 125 potassium gluconate, 2 NaCl, 0.2 CaCl 2 , 10 HEPES, 1 EGTA, 2 MgCl 2 , 2 Mg-ATP, 0.5 Na 2 -GTP, 10 Na 2 -phosphocreatine and 0.1 Alexa Fluor 647, with pH set to 7.1 using KOH. The high calcium buffering power internal solution contained BAPTA (tetrapotassium salt) and was similar but with the CaCl 2 and EGTA replaced with (in mM) 7 CaCl 2 and 30 BAPTA and with osmolarity differences compensated for by lowering the potassium gluconate concentration. The solution contained (in mM) 63 potassium gluconate, 2 NaCl, 7 CaCl 2 , 10 HEPES, 30 K 4 -BAPTA, 2 MgCl 2 , 2 Mg-ATP, 0.5 Na 2 -GTP, 10 Na 2 -phosphocreatine and 0.1 Alexa Fluor 647, with pH set to 7.1 using KOH. The free [Ca 2+ ] i was ~63 nM in both internal solutions, calculated using MaxChelator (http://maxchelator.stanford.edu/webmaxc/webmaxcS.htm) with the temperature set to 28 °C and ionic strength set to 140 mM.
The experimenter was blinded as to whether the pipette contained the low or high calcium buffering power solution.
Statistics. Data are shown as mean ± s.e.m., with individual data points superimposed. N values used for statistics were of cell processes, sheaths or somata, as appropriate. Normality of data was verified using the D' Agostino & Pearson omnibus test and equality of variance tested using the F statistic. Normally distributed data were analyzed using ANOVA and post hoc t tests or using paired t tests, as appropriate. For t tests, data were compared to interleaved controls using a homoscedastic, two-sided Student's t test (equal variance), except where the variances of the data were unequal, when a heteroscedastic, two-sided Student's t test was used. Data were corrected for multiple comparisons within figure panels using a procedure equivalent to the Holm-Bonferroni method (for N comparisons, the most significant P value is multiplied by N, the second-most significant by N -1, the third-most significant by N -2, etc.; corrected P values are significant if they are less than 0.05). Non-normally distributed data were analyzed with (two-tailed) Kruskal-Wallis tests followed by Dunn's multiple comparison tests or with Wilcoxon tests, as appropriate (in GraphPad Prism). Differences between processes and somata in Fig. 1h ,i were analyzed with two-way ANOVA followed by Holm-Sidak's multiple comparison test. Data in Fig. 2l -o were analyzed with twoway repeated-measures ANOVA followed by Holm-Sidak's multiple comparison test. Comparisons of the slopes of linear regressions with a slope of zero were performed using the t statistic for the regression. Comparison of the numbers of [Ca 2+ ] i transients or bursts in different process categories was done with χ 2 tests. Further details of statistical tests are available in Supplementary Table 1 .
An estimate of the sample size needed for a typical experiment is as follows. For a control response of 100%, a typical response s.d. of 40%, a response at a different developmental stage of 30% (70% less), a power of 80% and P < 0.05, 7 cell processes are needed (http://www.biomath.info/power/ttest.htm) in each of the two groups. The exact numbers depend on the effect size and standard error of the data. 
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Data exclusions
Describe any data exclusions.
No data points were excluded.
Replication
Describe whether the experimental findings were reliably reproduced.
We performed a minimum of 5 biological replicas for each experiment (i.e. n numbers were obtained from at least 5 different animals)
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Animals were randomly allocated to groups. In addition there was: (i) random interleaving of controls and stimulation experiments; and (ii) random interleaving of controls and BAPTA experiments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was done for experiments reported in Fig. 2 . Methods, section 'Electrical stimulation and pharmacology'.
For patch-clamping experiments the experimenter was blinded as to whether the pipette contained the low or high calcium buffer solution (Fig. 3k) . Methods, section 'Whole-cell patch-clamp loading of calcium buffer into oligodendrocytes in vivo' nature research | life sciences reporting summary June 2017
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Images were processed using: ImageJ 1.49s, including plug-ins: GECIquant1.0, StackReg, Simple Neurite Tracer Calcium transients were detected using a custom script written for MATLAB2015b Graphs and statistical analysis were carried out using GraphPad Prism 6
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No restrictions
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
No antibodies were used in this study 10 . 
